Therefore, we detected the expressions of a series of cytokines in HCC cells treated with betulin and lenvatinib and found that the decrease in IL-1β was the most dominant, and replenishment of human recombinant IL-1β protein rescued cell viability which was reduced by lenvatinib. The gene discussed is IL1B; the disease is hepatocellular carcinoma.